insurance coverage for glp 1 drugs Medicaid of and Spending on GLP-1s Some insurers are dropping GLP-1
Description
The question isn't whether oral GLP-1 therapy will reach the mass market
6,8,10,11 By mitigating psychotropic-associated weight gain, GLP-1RAs may reduce cardiometabolic burden and treatment discontinuation among those with mood disorders
Mojsov S
When heterogeneity was obvious (I 2 50 %), a random-effects model was used to summarize the RRs
